...
首页> 外文期刊>Digestive Diseases and Sciences >Ongoing challenges in the endoscopic management of hilar cholangiocarcinoma.
【24h】

Ongoing challenges in the endoscopic management of hilar cholangiocarcinoma.

机译:肝门胆管癌的内窥镜治疗中的挑战。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The majority of patients with cholangiocarcinoma present with locally unresectable disease and the median survival with radiation and chemotherapy is 7-12 months. The endoscopic palliation of inoperable hilar cholangiocarcinoma remains one of the more challenging cases for the biliary endoscopist. The endoscopist must define the anatomy without injecting contrast into ducts that will not be drained, achieve guide-wire access for unilateral or bilateral stent placement and determine what type of stent-plastic or self-expanding metal (SEMS), will best serve the patient to relieve pain and jaundice and prevent cholangitis.
机译:大多数胆管癌患者表现为局部无法切除的疾病,放疗和化疗的中位生存期为7-12个月。不能手术的肝门胆管癌的内镜缓解仍然是胆管内镜医师更具挑战性的病例之一。内镜医师必须确定解剖结构,而不要将造影剂注入不会引流的导管中,实现单侧或双侧支架置入的导丝进入,并确定哪种类型的支架塑料或自膨胀金属(SEMS),将最适合患者减轻疼痛和黄疸并预防胆管炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号